Finance > Venture Deals Database > Venture Transactions Database > Monthly Deals (All) > July 2012 VC Transactions
Histogenics

Tech Company Financing Transactions

Histogenics Funding Round

On 7/24/2012, Histogenics received $49 million in Series A funding from Sofinnova Ventures, Altima Partners and BioMed Ventures.

Transaction Overview

Company Name

Histogenics

Announced On

7/24/2012

Transaction Type

Venture Equity

Amount

$49,000,000

Round

Series A

Investors

Sofinnova Ventures (Lead Investor) (Garheng Kong)

Altima Partners

BioMed Ventures

Boston Millennia Partners

Flare Capital Partners (Lee Wrubel)

GIMV

Inflection Point Ventures

ProChon Holdings BV

Split Rock Partners (Josh Baltzell)

Proceeds Purpose

Proceeds will be used to complete the ongoing Phase 3 clinical program for lead product candidate NeoCart, which is currently enrolling patients. NeoCart is an autologous neocartilage tissue implant that utilizes the patient's own cells to regenerate cartilage in patients suffering from cartilage lesions in the knee. Funds will also support efforts to obtain regulatory clearance in the European Union for product candidate VeriCart, a single-step, cell-free collagen scaffold uniquely designed to be used in conjunction with the patient's own stem cells, to repair small cartilage defects frequently observed in meniscal and anterior cruciate ligament repair procedures.

Company Information

Company Status

Publicly-held

Industry

Medical Devices & Instruments

Mailing Address

830 Winter St. 3rd Floor
Waltham, MA 02451
USA

Phone

(781) 547-7900

Website

www.histogenics.com

Email Address

[email protected]

Overview

Histogenics (NASDAQ: HSGX) is a tissue regeneration company developing breakthrough treatments for long-lasting joint repair.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Adam Gridley

Chief Financial Officer

Jon Lieber

Chief Operating Officer

Stephen Kennedy

VP - Bus. Development

Donald Haut

VP - Engineering

Caroline Dugopolski

VP - Finance

Harris Shuman

VP - Operations

Peter Hamilton

Browse more venture capital transactions:

Prev: 7/24/2012: Tintri venture capital transaction
Next: 7/24/2012: Tillster venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary